<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8168717</identifier>
<setSpec>0300-9041</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Arredondo García, J L</dc:author>
<dc:author>Figueroa Damián, R</dc:author>
<dc:author>Ortiz Ibarra, F J</dc:author>
<dc:description xml:lang="en">Rabies infection in humans is still a major public health problem. A review of the literature shows 25 cases of pregnant human exposure to rabies virus. We report two patients with rabies exposure during the second and third trimester of pregnancy, that received immunization respectively with Vero cell vaccine and Fuenzalida vaccine. There were no repercutions in the products or in the mothers attributed to the prophylaxis, which appear safe when given during pregnancy. Because of the high likelihood of fatal disease following a rabid animal bite, this cases report supports the recommendation that pregnancy is not a contraindication to post-rabies exposure immunoprophylaxis.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>1994 Jan </dc:date>
<dc:title xml:lang="es">Profilaxis antirrábica postexposición en mujeres gestantes.</dc:title>
<dc:title xml:lang="en">[Post-exposure antirabies prophylaxis in pregnant women].</dc:title>
<dc:publisher>Ginecologia y obstetricia de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
